Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2021-05-27
Original market date: See footnote 1
2004-06-21
Product name:
ADVIL EXTRA STRENGTH LIQUI-GELS
DIN:
02248231
Product Monograph/Veterinary Labelling:
Date:
2020-05-07
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
450
55 Standish Court
Mississauga
Ontario
Canada
L5R 4B2
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
28:08.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
M01AE01 IBUPROFEN
Active ingredient group (AIG) number:See footnote5
0108883002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| IBUPROFEN | 400 MG |